16 results
·
26ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
LED Light Therapy Device, ELIXIR MD
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
OsteoMed
FDA UDI
OSTEOMED LLC·00845694023023·FPS 2.7 NC Fusion Plate Small
OsteoMed
FDA UDI
OSTEOMED LLC·00845694077620·FPS 2.7 NC Fusion Small Plate Sterile Qty 2
BIOPORE BALLOON DILATION CATHETER
FDA 510(k)
FDA Class 2
·Cardiovascular
PHOT-X IIS MODEL 505
FDA 510(k)
FDA Class 2
·Dental
LINEAR? ST
FDA Adverse Event
Injury
·BOSTON SCIENTIFIC NEUROMODULATION CORPORATION·Product code LGW·May 25, 2026
OMNIPOD INSULIN PUMP
FDA Adverse Event
Malfunction
·INSULET CORPORATION·Product code LZG·March 4, 2009
TANDEM T:SLIM INSULIN DELIVERY SYSTEM
FDA Adverse Event
Injury
·TANDEM DIABETES CARE·Product code LZG·July 28, 2016
FUJINON
FDA Adverse Event
Other
·FUJIFILM CORP.·Product code EOQ·December 13, 2012
FUJINON
FDA Adverse Event
Death
·FUJIFILM CORP.·Product code EOQ·December 13, 2012
FUJINON
FDA Adverse Event
Other
·FUJIFILM CORP.·Product code EOQ·December 13, 2012
ANGIO-SEAL DEVICE
FDA Adverse Event
Injury
·ST. JUDE MEDICAL·Product code MGB·November 20, 2008
HOMECHOICE AUTOMATED PD SET WITH CASSETTE
FDA Adverse Event
Malfunction
·BAXTER HEALTHCARE - MOUNTAIN HOME·Product code FKX·September 9, 2011
SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE
FDA Adverse Event
Injury
·BAXTER HEALTHCARE·Product code KDJ·July 22, 2013
ACCOLADE DR SL MRI (Model L311)
FDA Enforcement
Class I
·Ongoing·Boston Scientific Corporation·October 22, 2025
Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014